![](/img/cover-not-exists.png)
JAK-1/2 Inhibitor Ruxolitinib controls a case of Chilblain Lupus Erythematosus
Wenzel, Joerg, van Holt, Nadine, Maier, Judith, Vonnahme, Maria, Bieber, Thomas, Wolf, DominikLanguage:
english
Journal:
Journal of Investigative Dermatology
DOI:
10.1016/j.jid.2016.02.015
Date:
February, 2016
File:
PDF, 746 KB
english, 2016